We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Blood Biomarker POC Test Could Identify Patients at Risk of Severe Dengue

By LabMedica International staff writers
Posted on 26 Dec 2023
Print article
Image: Researchers have taken a step forward in diagnosing severe cases of dengue (Photo courtesy of NTU Singapore)
Image: Researchers have taken a step forward in diagnosing severe cases of dengue (Photo courtesy of NTU Singapore)

Dengue is typically a mild illness, yet approximately 15% of cases can progress to critical dengue, demanding intensive care and monitoring. Current early detection methods for severe dengue, such as PCR and ELISA tests conducted on blood samples, often fall short in sensitivity. Additionally, the World Health Organization's recommended symptom-based guidelines, which include fever, headache, eye pain, rash, and minor bleeding, have limited accuracy (6 to 18%) in detecting severe dengue due to symptom overlap with milder forms and other illnesses.

Scientists and clinicians at NTU Singapore (Singapore) have now identified two biomarkers — sST2 and suPAR — present in the blood of dengue patients that show promise in identifying those at risk of developing severe dengue during the disease's initial stages. This discovery emerged from a study between 2016 and 2019 involving 129 individuals treated for dengue. Given that lateral flow tests for sST2 and suPAR, proteins associated with heart health and disease, are commercially available for heart failure assessment, the team is exploring the possibility of combining these into a single test kit tailored for severe dengue detection.

Elevated levels of sST2 indicate cardiac stress and fibrosis, useful for gauging the severity of heart failure, while high suPAR levels are indicative of heightened inflammation and an increased risk of cardiac complications. By tracking these markers, researchers gain insights into cardiac conditions and disease progression. The team believes this novel approach could significantly improve accuracy in predicting severe dengue cases, with an estimated 55 to 60% accuracy rate, outperforming existing WHO guidelines. The development of these test kits could help healthcare professionals differentiate between mild dengue cases and severe ones requiring hospital admission.

Related Links:
NTU Singapore

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: A view of the brain with perturbation expression (Photo courtesy of Scripps Research)

Groundbreaking CRISPR Screen Technology Rapidly Determines Disease Mechanism from Tissues

Thanks to over a decade of advancements in human genetics, scientists have compiled extensive lists of genetic variations linked to a wide array of human diseases. However, understanding how a gene contributes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.